Tesla Germany sold 4,935 units in Q1 2025, reflecting a decline amid a broader electric vehicle uptick.

The German road traffic agency KBA reported Tesla’s March sales in Germany dropped 42.5% to 2,229 units year-over-year, with first-quarter figures plummeting 62.2% from 2024. KBA also noted a 35.3% rise in newly registered electric vehicles for March, highlighting a contrasting market trend.

According to its Q1 2025 report, Tesla’s global quarterly deliveries were 336,681 vehicles, a slight dip compared to Q1 2024’s 369,783 deliveries. Reuters attributed the dip to stiffer competition, factory retooling for the refreshed Model Y, and backlash tied to CEO Elon Musk’s political moves.

German Economy Minister Robert Habeck weighed in on Thursday, stating, “The perception is that the passion for Tesla has suffered greatly in recent weeks and months, which is perhaps a good opportunity for the automotive industry in Germany.”

Tesla Germany’s 62.2% drop in Q1 2025 sales might be tied more to Model Y production shifts rather than Musk’s image or brand perception.

Tesla saw a 156.87% jump in China in the third month of the first quarter, compared to February, when the company sold 30,688 units. Tesla China’s March wholesale figures hit 78,828 units, per CPCA data. Tesla started delivering its new Model Y vehicles in China last month.

Globally, Tesla produced 362,615 vehicles in Q1, including 345,454 Model 3 and Model Y units. However, it lost weeks of output during Model Y line upgrades at its Texas, Fremont, Shanghai, and Berlin factories.

Tesla noted that Model Y refresh production is scaling up in its Q1 delivery report. While Tesla might have a few challenges ahead, the company still has strong foundations for a stable future in the long term.

Recent news from China has revealed that the country’s best-selling car in March 2025 is also one of its newest. Despite deliveries in the country being ongoing for only a few weeks, the new Tesla Model Y ended March as the country’s best-selling vehicle.

In this article, we explore how the new Model Y was able to accomplish this feat despite its recent deliveries, as well as the reasons why the all-electric crossover was able to beat rivals from Chinese New Energy Vehicle (NEV) giant BYD.

The New Model Y’s Domination

Rankings from China last month indicate that Tesla was able to sell 43,370 new Model Y units in March 2025. This was despite the revamped all-electric crossover only starting domestic deliveries in late February. This means with just a few weeks’ worth of local deliveries, the new Model Y saw enough consumer interest to make it a best-seller.

A BYD Comparison

Skeptics might find it difficult to rationalize how a vehicle that sold 43,370 units became China’s best-selling car in March, especially since local automaker BYD sold far more new energy vehicles during the month. As per BYD, it sold a total of 395,091 units in March, though this is comprised of battery electric vehicles, plug-in hybrids, and commercial vehicles across its multiple brands. 

As noted in a CNEV Post report, BYD’s top seller in March 2025 was its Song family of vehicles, which sold 96,087 units. The Song family is comprised of the Song L EV, Song L DM-i, and Song Pro DM-i of the Dynasty series, as well as the Song Plus EV and Song Plus DM-i of the Ocean series. 

BYD’s second-best-selling vehicle is the Qin family, which sold 58,383 units in March. The Qin family includes the Qin Plus DM-i, Qin Plus EV, and the Qin L EV. In third place is the Seal family, which sold 44,563 units during the month. The BYD Seal family is comprised of vehicles like the Seal sedan, Seal 06 GT hatchback, Seal 07 DM-i, Seal 06 DM-i, and Seal U SUV.

Advantages of a Limited Lineup

Looking at BYD’s results in March, it is difficult not to be impressed by the Chinese automaker’s numbers. However, due to BYD’s immense vehicle lineup, such as the Song family comprising several models, each model’s raw sales numbers were lower than the new Model Y’s 43,370 units in March.

This is quite the advantage for Tesla’s lineup. Since Gigafactory Shanghai only produces the Model 3 and Model Y, the domestic sales of both vehicles are very concentrated. This may also be one of the reasons why the new Model Y’s sales in March proved enough to make the vehicle into China’s best-selling car, even if Giga Shanghai is still ramping its production of the all-electric crossover.

Just a Good Car

While Elon Musk’s political nature and close ties with U.S. President Donald Trump may play some role in Tesla’s sales in the United States and Europe, his political views may not be a factor at all for a good number of car buyers in China, which also happens to be the world’s largest electric vehicle market.

In China, at least, it appears that the Model Y is a popular choice for consumers simply because it is a vehicle that presents excellent value for its price. That’s a difficult combination to beat, even for BYD, which is currently China’s undisputed king of the NEV market.

Neuralink opened its patient registry to people globally, broadening access to its brain-computer interface trials.

“The Neuralink Patient Registry is now open globally! If you have quadriplegia and are interested in exploring groundbreaking ways to control a computer using your thoughts, you can now sign up from anywhere in the world,” the company announced in a recent X post.

Interested individuals can join by submitting their email through Neuralink’s patient portal.

The tech firm currently runs two feasibility trials: the PRIME Study and the CONVOY Study. While Neuralink didn’t clarify which study the registry targets, accepted patients are likely to participate in the PRIME Study, which is focused on its Link brain-computer interface (BCI). The CONVOY Study explores brain-controlled assistive robotic devices.

In February, Neuralink shared details on PRIME Study participants—Conrad, Alex, and Brad—who showcased transformative experiences with Link. Alex, a PRIME participant, also enrolled as the inaugural participant in the CONVOY Study. Unlike PRIME’s broad testing of Link, CONVOY zeroes in on controlling devices like an assistive robotic arm (ARA).

“ARA control expands autonomy beyond smart devices and could allow people with paralysis to perform tasks in daily life such as feeding themselves and handling physical objects,” Neuralink explained.

The global registry rollout marks a milestone for Neuralink, amplifying its reach to those with quadriplegia. With PRIME and CONVOY advancing, the company edges closer to merging human cognition with technology, potentially reshaping assistive solutions.